NSE: SUMICHEM · 26 October 2026
- Sumitomo Chemical India Ltd. shares are trading down 0.76% at ₹357.85, moving near the lower end of the day's narrow range between ₹353.25 and ₹360.55.
- Sumitomo Chemical India submitted the scrutinizer's report confirming the successful passage of all resolutions at its 26th Annual General Meeting held on July 27, 2026. Shareholders approved the audited financial statements for the year ended March 31, 2026, and a final dividend of ₹1.30 per share. Additionally, the board approved leadership changes, including the appointment of Dr. Suresh Ramachandran as Managing Director and Mr. Chetan Shah as Non-Executive Non-Independent Director effective September 1, 2026.
- Trading volume was 0.35 times the 20-day average daily volume.
Why is Sumitomo Chemical India share price falling on 26 October 2026?
Sumitomo Chemical India Ltd. shares are trading down 0.76% at ₹357.85, moving near the lower end of the day's narrow range between ₹353.25 and ₹360.55.
While the broader market benchmark Nifty edged up 0.1% and the Nifty Metal sector index advanced 1.18%, the stock lagged its sectoral peers. This muted price action comes alongside significant medium-term downward pressure, marked by a decline of 11.59% over the past 5 trading days and 20.42% over the past 20 trading days.
The recent price movement follows the company's annual general meeting held on July 27, 2026, where shareholders approved financial results, a dividend of ₹1.30 per share, and key leadership transitions including Dr. Suresh Ramachandran's appointment as Managing Director effective September 1, 2026.
1.11 lakh shares traded by 26 October 2026 · 10:40 AM IST. This compares with a 20-day average daily volume of 3.19 lakh shares (0.35 times). The five-day average daily volume was 2.63 lakh shares. Separately, the NSE report for 23 October 2026 showed 2.13 lakh shares delivered, representing 61.36% of that day’s traded volume. The same report recorded 13,833 trades.
The stock's decline of 0.76% occurs on light trading volume equal to 0.35 of its 20-day average, indicating a lack of strong institutional participation. As no fresh same-day catalysts are present, the move reflects persistent downward pressure following recent double-digit weekly losses rather than a specific operational event.
Latest Company Developments
Sumitomo Chemical India submitted the scrutinizer's report confirming the successful passage of all resolutions at its 26th Annual General Meeting held on July 27, 2026. Shareholders approved the audited financial statements for the year ended March 31, 2026, and a final dividend of ₹1.30 per share. Additionally, the board approved leadership changes, including the appointment of Dr. Suresh Ramachandran as Managing Director and Mr. Chetan Shah as Non-Executive Non-Independent Director effective September 1, 2026.
The AGM filings formalize key leadership changes and capital returns that shape the company's operational execution and governance going forward.
The company reported operating revenue of ₹1,063 crore for the quarter ended June 30, 2026, a modest 1% increase year-on-year amid an adverse operating environment marked by delayed monsoon rains. Gross profit improved 4% to ₹417 crore with margins expanding 111 basis points to 39.2%, while operating EBITDA grew 6% to ₹233 crore. Reported net profit rose 20% to ₹215 crore, aided by a ₹27 crore insurance claim for business interruption related to a historical plant fire.
These financial figures demonstrate earnings resilience and margin expansion despite headwinds from delayed kharif sowing and subdued domestic demand.
Mr. Ninad D. Gupte tendered his resignation as a Non-Executive, Non-Independent Director of the company for personal reasons, effective from the close of business hours on August 31, 2026. The company confirmed that there were no other material reasons underlying his departure.
Board departures require monitoring for governance continuity, though routine changes of non-executive directors typically have limited direct impact on near-term share price performance.
Integrated Filing (Financial) for the quarter ended 30th June, 2026.
Ownership & Transaction Activity
Mutual Fund Holdings
Mutual funds held 7.68% on 30 September 2026. This compares with 7.27% on 30 June 2026, a change of +0.41 percentage points.
The filing reported 33 MF/UTI holders.
What to Watch Next
- Progress of monsoon rainfall and subsequent recovery in kharif sowing acreage across domestic markets
- Execution of commercial product launches including Topgrain and Helibax during the current quarter
- Delivery participation relative to the 61.36% delivery percentage recorded on October 23, 2026
- Updates on ongoing legal proceedings concerning the regulatory notification on Glyphosate weedicide
More Sumitomo Chemical India news and dated analysis →
Frequently Asked Questions
What is the latest Sumitomo Chemical India company news?
Sumitomo Chemical India submitted the scrutinizer's report confirming the successful passage of all resolutions at its 26th Annual General Meeting held on July 27, 2026. Shareholders approved the audited financial statements for the year ended March 31, 2026, and a final dividend of ₹1.30 per share. Additionally, the board approved leadership changes, including the appointment of Dr. Suresh Ramachandran as Managing Director and Mr. Chetan Shah as Non-Executive Non-Independent Director effective September 1, 2026.
How strong was Sumitomo Chemical India’s trading volume?
1.11 lakh shares traded, 0.35 times the 20-day average daily volume. The price and volume data are dated 26 October 2026 · 10:40 AM IST.
Do the mutual-fund figures show buying today?
They show holdings on 30 September 2026. Quarterly holdings do not identify purchases made on the article date.
Research & analysis: WittyTrades Research Desk
Reviewed by: Mohanish Sanghavi — SEBI Registered Research Analyst
Disclaimer: Investments in securities markets are subject to market risks. Registration with SEBI and NISM certification do not guarantee performance or returns. This article is for information and education, not personalised investment advice or a recommendation to buy, sell or hold.